FLAGSTAFF, Ariz., July 1,
2019 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a
developer of proprietary technologies for managing animal pest
populations through fertility control, announced today that it has
been added to the Russell Microcap® Index effective after the
market close on Friday, June 28,
2019, as part of the Russell Indexes annual
reconstitution.
Ken Siegel, Chief Executive
Officer of SenesTech, said, "We are extremely pleased to have been
selected to join the Russell Microcap Index. We believe this will
significantly increase our visibility within the investment
community and we look forward to increasing the public awareness of
our EPA approved ContraPest, as a highly effective, proven, and
eco-friendly solution to controlling rat populations."
About FTSE Russell
FTSE Russell is a leading global
index provider creating and managing a wide range of indexes, data
and analytic solutions to meet client needs across asset classes,
style and strategies. Covering 98% of the investable market, FTSE
Russell indexes offer a true picture of global markets, combined
with the specialist knowledge gained from developing local
benchmarks around the world.
Membership in the Russell Microcap® Index, which
remains in place for one year, means automatic inclusion in the
appropriate growth and value style indexes. FTSE Russell determines
membership for its Russell indexes primarily by objective,
market-capitalization rankings and style attributes.
For more information on the Russell Indexes go to the
"Russell Reconstitution" section on the FTSE Russell
website.
About SenesTech
SenesTech has developed and is in the process of
commercializing a proprietary technology for managing animal pest
populations, primarily rat populations, through fertility control.
For more information visit the SenesTech website
at www.senestech.com.
Safe Harbor Statement
This release contains
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended and such
forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans,
results, or strategies and are generally preceded by words such as
"may," "future," "plan" or "planned," "will" or "should,"
"expected," "anticipates," "draft," "eventually" or "projected."
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors and other risks
identified in our filings with the Securities and Exchange
Commission. Forward looking statements include, but are not limited
to, our expectation regarding sales commitments, our expectation
regarding the conversion of sales commitments and programs to
revenue, our belief that our product is more humane, less harmful
to the environment and more effective than traditional methods, and
our belief that ContraPest will establish a new paradigm in rodent
control without environmental effects of rodenticides. All
forward-looking statements contained in this press release speak
only as of the date on which they were made and are based on
management's assumptions and estimates as of such date. We do not
undertake any obligation to publicly update any forward-looking
statements, whether as a result of the receipt of new information,
the occurrence of future events or otherwise.
CONTACT:
Investor: Robert Blum,
Joe Dorame, Joe Diaz, Lytham Partners, LLC, 602-889-9700,
senestech@lythampartners.com
Company: Tom Chesterman, Chief
Financial Officer, SenesTech, Inc., 928-779-4143
View original
content:http://www.prnewswire.com/news-releases/senestech-joins-the-russell-microcap-index-300878343.html
SOURCE SenesTech, Inc.